Salts of prodrugs of piperazine and substituted piperidine antiviral agents

Abstract

This invention provides for prodrug Compounds I, pharmaceutical compositions thereof, and their use in treating HIV infection. wherein: X is C or N with the proviso that when X is N, R 1 does not exist; W is C or N with the proviso that when W is N, R 2 does not exist; V is C; E is hydrogen or a pharmaceutically acceptable salt thereof; and Y is selected from the group consisting of Also, this invention provides for intermediate Compounds II useful in making prodrug Compounds I. wherein: L and M are independently selected from the group consisting of C 1 -C 6 alkyl, phenyl, benzyl, trialkylsilyl, -2,2,2-trichloroethoxy and 2-trimethylsilylethoxy.

What is claimed is: 
     
         1 . A method for treating a mamal infected with the HIV virus comprising administering to said mamal a pharmaceutically acceptable salt of the compound 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, having the following structure: 
       
         
           
           
               
               
           
         
       
     
     
         2 . The method of  claim 1  further comprising the administration of a second AIDS treatment agent selected from the group consisting of AIDS antiviral agents, anti-infective agents, immunomodulators, and HIV entry inhibitors. 
     
     
         3 . A pharmaceutical composition comprising a pharmaceutically acceptable salt of the compound 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, having the following structure: 
       
         
           
           
               
               
           
         
       
     
     
         4 . The pharmaceutical composition of  claim 3  further comprising a second AIDS treatment agent selected from the group consisting of AIDS antiviral agents, anti-infective agents, immunomodulators, and HIV entry inhibitors.